-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Evolution Directed Gene Engineering (EDGE) Identifies Single Amino Acid Substitutions in FVIII with Six-Fold Increased in Vitro and In Vivo Activity

Program: Scientific Symposia
Session: Special Symposium on the Basic Science in Hemostasis and Thrombosis
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, Translational Research, hemophilia, Diseases, Technology and Procedures
Monday, December 11, 2023, 4:30 PM-6:00 PM

Lucas Van Gorder

The Children's Hospital of Philadelphia, Boston, MA

Disclosures: Van Gorder: Frontera Therapeutics: Current Employment.

Previous Presentation | Next Presentation >>